ConductScience.org, home

Paper219367

Retinoic acid inhibition of Epstein-Barr virus induction.

Yamamoto N and 2 others. Nature, 1979. Cited by 75 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Retinoic acid inhibition of Epstein-Barr virus induction. Papers, record 219367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/219367

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Retinoic acid inhibition of Epstein-Barr virus induction.
PubMed
Journal
Nature
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
75
iCite
Relative citation ratio, by iCite
2.18
iCite
Revised in PubMed
2019-06-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yamamoto NN
2Bister KK
3zur Hausen HH

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Herpesvirus 4, HumanMajor topic
TretinoinMajor topic
Virus ReplicationMajor topic
Vitamin AMajor topic
Antibodies, Anti-Idiotypic
Antigens, Viral
Cell Line
Depression, Chemical
Humans
Immunoglobulin M
Tetradecanoylphorbol Acetate

Source PubMed

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.

PMIDTitleJournalYearIn PapersSource
22,357,272Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.J Virol2012https://conductscience.org/library/papers/22357272PubMed
10,022,850The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus.Mol Cell Biol1999https://conductscience.org/library/papers/10022850PubMed
8,387,200Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8387200PubMed
8,382,295Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines.J Virol1993https://conductscience.org/library/papers/8382295PubMed
7,406,477Mechanism of virucidal activity of retinoids: protein removal from bacteriophage phi 6 envelope.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7406477PubMed
7,294,881Immunological features of psoriasis. Effects of Ro-109359, concanavalin A, pokeweed mitogen, and methotrexate on cultivated lymphocytes.Arch Dermatol Res1981https://conductscience.org/library/papers/7294881PubMed
6,254,085Expression of cloned hepatitis B virus DNA in human cell cultures.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6254085PubMed
2,836,712Differential expression of the major histocompatibility antigen complex (MHC) on a series of Burkitt's lymphoma lines.Microbiol Immunol1987https://conductscience.org/library/papers/2836712PubMed
394,876Retinoids and cancer.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/394876PubMed
228,596Virucidal activity of retinal.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/228596PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/219367

GET https://conductscience.org/api/papers/v1/219367/authors